Literature DB >> 26815310

Usefulness of PET Imaging to Guide Treatment Options in Gliomas.

Bogdana Suchorska1, Nathalie Lisa Albert2, Jörg-Christian Tonn3.   

Abstract

OPINION STATEMENT: Magnetic resonance imaging (MRI) is the gold standard guiding diagnostic and therapeutic management in glioma with its high resolution and possibility to depict blood-brain-barrier disruption when contrast medium is applied. In light of the shifting paradigms revealing distinct tumor subtypes based on the molecular and genetic characterization and increasing knowledge about the variability of glioma biology, additional imaging modalities such as positron emission tomography (PET) depicting metabolic processes gain further importance in the management of glioma.

Entities:  

Keywords:  Glioma; Imaging; PET

Year:  2016        PMID： 26815310     DOI： 10.1007/s11940-015-0384-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN： 1092-8480            Impact factor:   3.598


  41 in total

1.  MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

Authors:  Nathalie L Jansen; Vera Graute; Lena Armbruster; Bogdana Suchorska; Juergen Lutz; Sabina Eigenbrod; Paul Cumming; Peter Bartenstein; Jörg-Christian Tonn; Friedrich Wilhelm Kreth; Christian la Fougère
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-11       Impact factor: 9.236

Review 2.  Radiolabeled amino acids for oncologic imaging.

Authors:  Chaofeng Huang; Jonathan McConathy
Journal:  J Nucl Med       Date:  2013-05-24       Impact factor: 10.057

3.  Comparison of stereotactic brain biopsy to interventional magnetic-resonance-imaging-guided brain biopsy.

Authors:  W A Hall; H Liu; A J Martin; C L Truwit
Journal:  Stereotact Funct Neurosurg       Date:  1999       Impact factor: 1.875

4.  Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.

Authors:  Lutz W Kracht; Hrvoje Miletic; Susanne Busch; Andreas H Jacobs; Jurgen Voges; Moritz Hoevels; Johannes C Klein; Karl Herholz; Wolf-D Heiss
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

5.  FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Authors:  Gabriele Pöpperl; Friedrich W Kreth; Jan H Mehrkens; Jochen Herms; Klaus Seelos; Walter Koch; Franz J Gildehaus; Hans A Kretzschmar; Jörg C Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

6.  [18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma.

Authors:  Nathalie L Jansen; Bogdana Suchorska; Silke B Schwarz; Sabina Eigenbrod; Juergen Lutz; Vera Graute; Peter Bartenstein; Claus Belka; Friedrich W Kreth; Christian la Fougère
Journal:  Mol Imaging       Date:  2013-05       Impact factor: 4.488

7.  Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity.

Authors:  T Kato; J Shinoda; N Oka; K Miwa; N Nakayama; H Yano; T Maruyama; Y Muragaki; T Iwama
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-07       Impact factor: 3.825

8.  Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study.

Authors:  K Herholz; U Pietrzyk; J Voges; R Schröder; M Halber; H Treuer; V Sturm; W D Heiss
Journal:  J Neurosurg       Date:  1993-12       Impact factor: 5.115

9.  Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.

Authors:  Benoit Pirotte; Serge Goldman; Nicolas Massager; Philippe David; David Wikler; Arlette Vandesteene; Isabelle Salmon; Jacques Brotchi; Marc Levivier
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

10.  PET imaging in the surgical management of pediatric brain tumors.

Authors:  Benoit Pirotte; Francesco Acerbi; Alphonse Lubansu; Serge Goldman; Jacques Brotchi; Marc Levivier
Journal:  Childs Nerv Syst       Date:  2007-03-14       Impact factor: 1.532
View more
  8 in total

1.  TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma.

Authors:  Nathalie L Albert; M Unterrainer; D F Fleischmann; S Lindner; F Vettermann; A Brunegraf; L Vomacka; M Brendel; V Wenter; C Wetzel; R Rupprecht; J-C Tonn; C Belka; P Bartenstein; M Niyazi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-19       Impact factor: 9.236

Review 2.  Use of PET Imaging in Neuro-Oncological Surgery.

Authors:  Adrien Holzgreve; Nathalie L Albert; Norbert Galldiks; Bogdana Suchorska
Journal:  Cancers (Basel)       Date:  2021-04-26       Impact factor: 6.639

3.  Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties?

Authors:  Alexander Romagna; Marcus Unterrainer; Christine Schmid-Tannwald; Matthias Brendel; Jörg-Christian Tonn; Silke Birgit Nachbichler; Alexander Muacevic; Peter Bartenstein; Friedrich-Wilhelm Kreth; Nathalie Lisa Albert
Journal:  Radiat Oncol       Date:  2016-10-21       Impact factor: 3.481

4.  O-(2-[18F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres.

Authors:  Christian P Filss; Nathalie L Albert; Guido Böning; Elena Rota Kops; Bogdana Suchorska; Gabriele Stoffels; Norbert Galldiks; Nadim J Shah; Felix M Mottaghy; Peter Bartenstein; Jörg C Tonn; Karl-Josef Langen
Journal:  EJNMMI Res       Date:  2017-08-16       Impact factor: 3.138

5.  MEG-3-mediated Wnt/β-catenin signaling pathway controls the inhibition of tunicamycin-mediated viability in glioblastoma.

Authors:  Xiangyu Cui; Dezhou Sun; Bin Shen; Xin Wang
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

6.  Natural Diterpenoid Isoferritin A (IsoA) Inhibits Glioma Cell Growth and Metastasis via Regulating of TGFβ-Induced EMT Signal Pathway.

Authors:  Bin Shen; Dezhou Sun
Journal:  Med Sci Monit       Date:  2018-06-06

Review 7.  Applications of Artificial Intelligence Based on Medical Imaging in Glioma: Current State and Future Challenges.

Authors:  Jiaona Xu; Yuting Meng; Kefan Qiu; Win Topatana; Shijie Li; Chao Wei; Tianwen Chen; Mingyu Chen; Zhongxiang Ding; Guozhong Niu
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

8.  Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.

Authors:  Linzhi Cai; Sabrina V Kirchleitner; Dongxu Zhao; Min Li; Jörg-Christian Tonn; Rainer Glass; Roland E Kälin
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.